CISATRACURIUM BESYLATE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cisatracurium Besylate Preservative Free, and what generic alternatives are available?
Cisatracurium Besylate Preservative Free is a drug marketed by Accord Hlthcare, Eugia Pharma, Fresenius Kabi Usa, Hainan Poly, Hengrui Pharma, Sandoz Inc, and Somerset Theraps Llc. and is included in seven NDAs.
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cisatracurium Besylate Preservative Free
A generic version of CISATRACURIUM BESYLATE PRESERVATIVE FREE was approved as cisatracurium besylate by SANDOZ INC on February 3rd, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CISATRACURIUM BESYLATE PRESERVATIVE FREE?
- What are the global sales for CISATRACURIUM BESYLATE PRESERVATIVE FREE?
- What is Average Wholesale Price for CISATRACURIUM BESYLATE PRESERVATIVE FREE?
Summary for CISATRACURIUM BESYLATE PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 63 |
| DailyMed Link: | CISATRACURIUM BESYLATE PRESERVATIVE FREE at DailyMed |
Pharmacology for CISATRACURIUM BESYLATE PRESERVATIVE FREE
| Drug Class | Nondepolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
US Patents and Regulatory Information for CISATRACURIUM BESYLATE PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 205872-001 | Jun 16, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hainan Poly | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 216539-002 | Aug 27, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 203182-001 | Feb 26, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Somerset Theraps Llc | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 206791-001 | Feb 20, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hengrui Pharma | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 204960-001 | Jan 27, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
